Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004153 (
atherosclerosis
)
77,401
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Plasminogen activator inhibitor type 1 (PAI-1) is a major physiologic regulator of the fibrinolytic system and has recently gained recognition as a modulator of inflammation and
atherosclerosis
. PAI-1 exhibits circadian rhythmicity in its expression, peaking in the early morning, which is associated with increased risk for cardiovascular events. However, the mechanisms that determine PAI-1 circadian rhythmicity remain poorly understood. We discovered that the orphan nuclear receptor
Rev-erb alpha
, a core component of the circadian loop, represses human PAI-1 gene expression through two
Rev-erb alpha
binding sites in the PAI-1 promoter. Mutations of these sites, as well as RNA interference targeting endogenous
Rev-erb alpha
and its corepressors, led to increased expression of the PAI-1 gene. Furthermore, glycogen synthase kinase 3beta (GSK3beta) contributes to pai-1 repression by phosphorylating and stabilizing
Rev-erb alpha
protein, which can be blocked by lithium. Interestingly, serum shock generated circadian oscillations in PAI-1 mRNA in NIH3T3 cells, suggesting that PAI-1 is a direct output gene of the circadian loop. Ectopic expression of a stabilized form of
Rev-erb alpha
that mimics GSK3beta phosphorylation dramatically dampened PAI-1 circadian oscillations. Thus, our results suggest that
Rev-erb alpha
is a major determinant of the circadian PAI-1 expression and a potential modulator of the morning susceptibility to myocardial infarction.
...
PMID:The orphan nuclear receptor Rev-erb alpha regulates circadian expression of plasminogen activator inhibitor type 1. 1696 9
Normal physiological processes are under control of circadian rhythms. Moreover, certain pathological events, such as cardiovascular accidents (myocardial infarction, stroke) occur more frequently at specific times of the day. Recent observations demonstrate a causal relationship between alterations in circadian rhythmicity and metabolic disorders. Disruption of clock genes results in dyslipidemia, insulin resistance and obesity, all predisposing to
atherosclerosis
. The nuclear receptor
Rev-erb alpha
is part of the clock circuitry and plays an important role in keeping proper timing of the clock.
Rev-erb alpha
also regulates lipid metabolism, adipogenesis and vascular inflammation. Interestingly,
Rev-erb alpha
also cross-talks with several other nuclear receptors involved in energy homeostasis. Therefore
Rev-erb alpha
may serve to couple metabolic and circadian signals.
...
PMID:Rev-erb alpha gives a time cue to metabolism. 1776 29